GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Diamond Biofund Inc (TPE:6901) » Definitions » Debt-to-Equity

Diamond Biofund (TPE:6901) Debt-to-Equity : 0.01 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Diamond Biofund Debt-to-Equity?

Diamond Biofund's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$23.90 Mil. Diamond Biofund's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$93.93 Mil. Diamond Biofund's Total Stockholders Equity for the quarter that ended in Dec. 2024 was NT$10,373.05 Mil. Diamond Biofund's debt to equity for the quarter that ended in Dec. 2024 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Diamond Biofund's Debt-to-Equity or its related term are showing as below:

TPE:6901' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.01   Max: 0.02
Current: 0.01

During the past 6 years, the highest Debt-to-Equity Ratio of Diamond Biofund was 0.02. The lowest was 0.00. And the median was 0.01.

TPE:6901's Debt-to-Equity is ranked better than
99.9% of 975 companies
in the Asset Management industry
Industry Median: 0.19 vs TPE:6901: 0.01

Diamond Biofund Debt-to-Equity Historical Data

The historical data trend for Diamond Biofund's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamond Biofund Debt-to-Equity Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial 0.01 - - 0.01 0.01

Diamond Biofund Quarterly Data
Dec19 Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Competitive Comparison of Diamond Biofund's Debt-to-Equity

For the Asset Management subindustry, Diamond Biofund's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diamond Biofund's Debt-to-Equity Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Diamond Biofund's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Diamond Biofund's Debt-to-Equity falls into.


;
;

Diamond Biofund Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Diamond Biofund's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Diamond Biofund's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diamond Biofund  (TPE:6901) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Diamond Biofund Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Diamond Biofund's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamond Biofund Business Description

Traded in Other Exchanges
N/A
Address
No. 236, Section 4, Xinyi Road,, 11th Floor, Daan District, Taipei City, TWN, 106047
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting global and internationally competitive investment targets, including new drug research and development, high-end medical equipment, innovative medical service technology, medical access, agricultural biotechnology.

Diamond Biofund Headlines

No Headlines